Qiming Corporate GP VI, Ltd., 10% Owner at Alamar Biosciences, Inc. (ALMR), sold 185,731 shares at $30.33 ($6.0M) on 2026-10-27, disclosed to the SEC on 2026-10-29.
Open-market sale of $6.0M ALMR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.33 | 4,960 | $150K | 2.5% |
| 2 | $30.33 | 134 | $4K | 0.1% |
| 3 | $30.33 | 1,386 | $42K | 0.7% |
| 4 | $30.33 | 1,157 | $35K | 0.6% |
| 5 | $31.33 | 8,178 | $256K | 4.3% |
| 6 | $31.33 | 9,791 |
| $307K |
| 5.1% |
| 7 | $31.33 | 943 | $30K | 0.5% |
| 8 | $31.33 | 35,049 | $1.1M | 18.4% |
| 9 | $31.88 | 15,131 | $482K | 8.1% |
| 10 | $31.88 | 408 | $13K | 0.2% |
| 11 | $31.88 | 3,531 | $113K | 1.9% |
| 12 | $31.88 | 4,226 | $135K | 2.3% |
| 13 | $32.47 | 948 | $31K | 0.5% |
| 14 | $32.47 | 9,846 | $320K | 5.4% |
| 15 | $32.47 | 8,224 | $267K | 4.5% |
| 16 | $32.47 | 35,248 | $1.1M | 19.2% |
| 17 | $33.11 | 8,450 | $280K | 4.7% |
| 18 | $33.11 | 7,058 | $234K | 3.9% |
| 19 | $33.11 | 814 | $27K | 0.5% |
| 20 | $33.11 | 30,249 | $1.0M | 16.8% |
| Total | $32.14 avg | 185,731 | $6.0M | 100% |
| Filing → |
| ALMR | SELL | 2026-10-19 | $4.8M | — | Filing → |